Idropranolol
- Level
- Commodity
- Parent
- 51263100
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263110This classification denotes a beta-adrenergic blocking agent with the molecular formula C16H23NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5U6118QYHK, chemically known as 1-((5,6-dihydro-1-naphthyl)oxy)-3-(isopropylamino)-2-propanol but generally known as idropranolol, which bears US NIH Compound Identifier 163314. European Medicines Agency schedules Idropranolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08122MIG. The term IDROPRANOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). IDROPRANOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule idropranolol under HS 29221980 and SITC 51461. As of Q4 2014, IDROPRANOLOL remains the US FDA Preferred Term for this commodity. Idropranolol bears US NLM identifiers UMLS ID C2827192 and NCI Concept Code C83781. SMILES: O(CC(O)CNC(C)C)C1C2C(CCC=C2)CCC1.
Same parent
Under 51263100 · 75Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.